
Goldline Pharmaceutical
Open Date
May 12, 2026
Close Date
May 14, 2026
Min Investment
₹2,58,000
Lot Size
6000 Shares
Issue Size
₹11.61 Cr
Price Range
₹41 - ₹43
Listing Date
May 19, 2026
IPO Doc
RHP PDFAbout Goldline Pharmaceutical
Goldline Pharmaceuticals has engaged itself in marketing pharmaceutical products branded as 'Goldline'. The product line of Goldline can be categorized into five groups: Goldline Pharma: It includes a range of 42 products for specialties including Physicians, Orthopedics, ENT, Chest Physicians, General and Specialty Surgery, Gastroenterology, Neurology, and Urology. Goldline Cardinal: It consists of a range of 54 products for the Specialty division in medical fields such as Physicians, Diabetologists, Endocrinologists, Cardiologists, and General Physicians. Goldline Aayushman: It consists of a range of 18 products for the Specialty division in medical fields such as Pediatricians, Child Specialists, Neonatologists, and General Practitioners. Goldline InLife: It includes a range of 22 products for the Specialty division in medical fields such as Intensivists, Critical Care Consultants, Super Specialty Surgeons, and Physicians. Goldline Wellness: It consists of a range of 10 products for Supportive care for patients undergoing chemotherapy for their illness. As the company does not manufacture any products, it collaborates with third parties which manufacture medicines according to market analysis and product specifications of the company. The firm does not produce any products but rather works with third-party producers who manufacture their products as per the firm's market research and product descriptions, thus ensuring quality and regulatory compliance.Their products are all marketed and sold using the Goldline brand name by our distribution partners who distribute the products to retailers and wholesalers. Currently, the firm uses 15 producers and 7 distribution firms for selling its products, and it also helps hospitals and healthcare institutions in procurement and supplies. The firm sells products in the states of Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar.
Checklist Quality Analysis
Revenue Growth
Company Valuation
Earning Expansion
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.
Goldline Pharmaceutical IPO - Issue Objectives
The company will use ₹8.35 crore for repayment of borrowings availed by it. Part of the IPO proceeds will be used for general corporate purposes and issue expenses
Repayment of debt
69.62%
General corporate purpose
30.38%
Repayment of debt
The company will use ₹8.35 crore for repayment of borrowings availed by it.
General corporate purpose
Part of the IPO proceeds will be used for general corporate purposes and issue expenses
IPO Subscription Status
Financials of Goldline Pharmaceutical
In Cr.
Contact Details
Goldline Pharmaceutical
103, F-1, Leela Apartment, Shilpa HSG Society, Near Saptagiri Nagar, Shanidham, Narendra Nagar, Nagpur, Maharashtra - 440015.
Goldline Pharmaceutical IPO - FAQs
Live IPOs
CMR Green Technologies
Vahh Chemicals
UHM Vacation
| Companies Name | Open - Close | Issue Size | Min. Qty | Issue Price | Apply |
|---|---|---|---|---|---|
CMR Green Technologies Mainboard BSE NSE | 3rd Jun 2026 - 5th Jun 2026 | 630.88 Cr | 78 Shares | ₹ 182.00 | |
Vahh Chemicals SME | 4th Jun 2026 - 8th Jun 2026 | 13.45 Cr | 2000 Shares | ₹ 60.00 | |
UHM Vacation SME | 4th Jun 2026 - 8th Jun 2026 | 36.02 Cr | 800 Shares | ₹ 166.00 | |
Hexagon Nutrition Mainboard | 5th Jun 2026 - 9th Jun 2026 | 138.87 Cr | 333 Shares | ₹ 42.00 |